Literature DB >> 9566756

Identification and characterization of cytosolic sulfotransferases in normal human endometrium.

J L Falany1, R Azziz, C N Falany.   

Abstract

Understanding the factors which alter estrogen metabolism and activity in endometrial tissue is important because unopposed estrogen stimulation is an important risk factor in the development of endometrial carcinoma. The cyclic progression of the endometrium through proliferative and secretory phases is normally under the control of the ovarian hormones beta-estradiol (E2) and progesterone. One mechanism by which progesterone inhibits the activity of E2 in secretory endometrium is by elevating the degree of E2 sulfation, thereby reducing its ability to bind to the estrogen receptor and elicit a cellular response. Our laboratories have investigated the cytosolic sulfotransferases (STs) found in biopsies of both proliferative and secretory endometrium obtained from five normal pre-menopausal women who were not taking any drugs or steroids. Two of the human cytosolic STs were detected in human endometrial tissues. The phenol-sulfating form of phenol ST (P-PST) was found at varying levels in cytosol from both proliferative and secretory endometrium in all of the women studied but with no consistent correlation to the phase of the menstrual cycle. In contrast, estrogen ST (EST) was not detected in the proliferative endometrial cytosol of any of the women studied but was consistently found in all of the secretory endometrial cytosols. The presence and levels of these STs was confirmed by ST activity studies, immunoblot analysis and Northern blot analysis. These results indicate that the expression of EST in human endometrial tissues varies with the phase of the menstrual cycle and is most likely regulated by progesterone secreted from the ovaries.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566756     DOI: 10.1016/s0009-2797(97)00143-9

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  13 in total

Review 1.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

2.  Regulation of hepatic sulfotransferase (SULT) 1E1 expression and effects on estrogenic activity in cystic fibrosis (CF).

Authors:  Charles N Falany; Dongning He; Li Li; Josie L Falany; Teresa W Wilborn; Thomas A Kocarek; Melissa Runge-Morris
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03-03       Impact factor: 4.292

3.  The effects of endoxifen and other major metabolites of tamoxifen on the sulfation of estradiol catalyzed by human cytosolic sulfotransferases hSULT1E1 and hSULT1A1*1.

Authors:  Edwin J Squirewell; Michael W Duffel
Journal:  Drug Metab Dispos       Date:  2015-03-27       Impact factor: 3.922

Review 4.  Sulfotransferase genetic variation: from cancer risk to treatment response.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Drug Metab Rev       Date:  2013-09-06       Impact factor: 4.518

5.  Repression of CFTR activity in human MMNK-1 cholangiocytes induces sulfotransferase 1E1 expression in co-cultured HepG2 hepatocytes.

Authors:  Dongning He; Teresa W Wilborn; Josie L Falany; Li Li; Charles N Falany
Journal:  Biochim Biophys Acta       Date:  2008-09-11

Review 6.  Metabolic pathways involved in 2-methoxyestradiol synthesis and their role in preeclampsia.

Authors:  Alejandra Perez-Sepulveda; Pedro P España-Perrot; Errol R Norwitz; Sebastián E Illanes
Journal:  Reprod Sci       Date:  2013-03-01       Impact factor: 3.060

7.  Interactions of the human cytosolic sulfotransferases and steroid sulfatase in the metabolism of tibolone and raloxifene.

Authors:  Josie L Falany; Charles N Falany
Journal:  J Steroid Biochem Mol Biol       Date:  2007-06-26       Impact factor: 4.292

Review 8.  Pharmacogenetics of soluble sulfotransferases (SULTs).

Authors:  Hansruedi Glatt; Walter Meinl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-05       Impact factor: 3.000

9.  Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics.

Authors:  Araba A Adjei; Bianca A Thomae; Janel L Prondzinski; Bruce W Eckloff; Eric D Wieben; Richard M Weinshilboum
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs.

Authors:  Melissa Runge-Morris; Thomas A Kocarek
Journal:  PPAR Res       Date:  2009-08-10       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.